---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-25-000078"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T16:14:41.227905+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BeiGene issues 133M shares internally for re-domiciliation from Cayman to Switzerland

## Summary
- Issued 133,000,000 ordinary shares to subsidiary BGNC2 in exchange for 13.7% of BeiGene UK Ltd.
- Shares will be deemed treasury shares under Swiss law upon completion of planned re-domiciliation.
- Issuance relies on Section 4(a)(2) exemption; shares will be cancelled if re-domiciliation abandoned.
- Shares held for benefit of equity award holders under the 2016 Share Option and Incentive Plan.
- Swiss issuance stamp tax and withholding tax exemptions apply as shares are created before re-domiciliation.

## SEC filing metadata
- accession: 0001651308-25-000078
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000078/0001651308-25-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130825000078/bgne-20250513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-25-000078
- JSON: https://secwatch.observer/filing/0001651308-25-000078.json
- Plain text: https://secwatch.observer/filing/0001651308-25-000078.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.